Lasa Supergenerics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 ,inter alia, to consider and approve 1. To consider, approve and take on records unaudited financial results of the Company along with the Limited Review Report for the quarter and half year ended on September 30, 2024. 2. To discuss any other matter with the permission of the Chairperson. In accordance with the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015 and Company's Code of Conduct, the Trading Window shall continue to remain closed till 48 hours after the declaration of the unaudited financial results of the Company for the quarter and half year ended September 30, 2024. This Intimation is also available on the company's website at www.lasalabs.com and on the website of the stock Exchange at www.bseindia.com and www.nseindia.com .